Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST‐Segment–Elevation Myocardial Infarctions

BACKGROUND: Current guidelines recommend the new‐generation P2Y12‐inhibitor ticagrelor for patients with acute ST‐segment–elevation myocardial infarctions (STEMIs). The aim of the present study was to assess efficacy and safety of ticagrelor for elderly patients with STEMI (≥75 years) in an all‐come...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmucker, Johannes, Fach, Andreas, Mata Marin, Luis Alberto, Retzlaff, Tina, Osteresch, Rico, Kollhorst, Bianca, Hambrecht, Rainer, Pohlabeln, Hermann, Wienbergen, Harm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818018/
https://www.ncbi.nlm.nih.gov/pubmed/31538856
http://dx.doi.org/10.1161/JAHA.119.012530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818018/
https://www.ncbi.nlm.nih.gov/pubmed/31538856
http://dx.doi.org/10.1161/JAHA.119.012530

Ejemplares similares